-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Talents are the primary productive force.
For China's pharmaceutical industry, as a high-end manufacturing industry, it started late and the transformation is imminent.
Top 20 doctoral teams in A-share listed pharmaceutical companies
Data source: annual reports of listed companies
From the above data, 11 have more than 100 doctors, and 10 have increased in the number of doctors for three consecutive years.
The following is a further introduction to the personnel of the above four companies
WuXi AppTec has 21,942 R&D personnel, an increase of 23% year-on-year, and the number of doctors ranked first, an increase of 11.
WuXi AppTec,
Source: Company Annual Report
Hengrui Pharmaceuticals, despite the fact that Hengrui’s sales staff account for the largest proportion, but Hengrui ranks first in R&D expenses.
Hengrui Medicine,
Source: Company Annual Report
Fosun Pharma has 2,258 R&D employees in 2020, an increase of 5% year-on-year, and R&D expenses are not hesitating, increasing to RMB 4 billion, accounting for 13.
Fosun Pharma,
Source: Company Annual Report
Ganli Pharmaceutical is a representative of a field that has been deeply cultivated
Gan Li Pharmaceutical,
Source: Company Annual Report
Judging from market data, while high-end talents are increasing rapidly, the market value of companies is also rising sharply.
The market value growth of the above four companies from 2018 to 2020
In short, in ancient times, the crouching dragon and phoenix chicks were safe in the world
